All eyes are on AstraZeneca's vaccine trials as the company has emerged as the leading candidate for production of a vaccine after positive results were noted from its preliminary stage human trials.
"Following deliberation, it has recommended that permission be granted for the phase 2 and 3 human clinical trials of the potential vaccine developed by the Oxford University - Covishield", an official source said.
A United States says that the government in talks with private companies to build technology for monitoring COVID-19 vaccine deployment - according to Reuters reporting on the press conference.
Discussing the key aspects that will help reduce in lag between the trials and manufacturing of COVID-19 vaccine, Dr Fauci said that it is important to ensure regulatory standards and review, harmonised data monitoring which will foster comparability, and financing the advanced vaccine production.
They said that the SII had submitted a revised proposal on Wednesday after the expert panel on Tuesday, following deliberations over its application, had asked it to revise its protocol for the trials besides seeking some additional information.
In the first phase of the vaccine distribution, the pharmaceutical giant of Britain is aiming to procure more than two billion doses of its experimental vaccine.
The company has promised not to make profits from the potential vaccine against the coronavirus. "This is the kind of time in history when humanity, humankind is really threatened as a whole", Soriot said.
Soumya Swaminathan told a news briefing in Geneva that the more countries that joined COVAX, a scheme created to guarantee fast and equitable access globally to COVID-19 vaccines, the greater its chances of success.